Vishuo Thailand provides integrated omics and bioinformatics services—Genomics, Transcriptomics, Proteomics, Metabolomics—to empower precision research and healthcare in Thailand and beyond. Vishuo Biomedical (Thailand) LTD, established in 2016, is a healthcare technology and innovation-driven company that provides integrated solutions in Genomics, Transcriptomics, Proteomics, Metabolomics, and Bi
oinformatics. As one of the pioneers in Next Generation Sequencing (NGS) and omics data analysis in Thailand, we deliver end-to-end services from sample processing, sequencing, data analysis, to biological interpretation—empowering researchers, clinicians, universities, and industries with actionable insights.
Our team of expert bioinformaticians and scientists specializes in delivering customized analysis workflows tailored for clinical diagnostics, research discovery, and translational applications. With proprietary technologies, validated pipelines, and cross-disciplinary expertise, we support a wide range of applications such as infectious disease, rare disease, cancer genomics, microbiome, and personalized medicine. Our technologies and platforms, such as the iCMDB (integrated Clinical Molecular Diagnostics Base), have been applied in top-tier hospitals and institutions across Singapore, China, Thailand, and the United States. The iCMDB platform is ISO13485 certified and classified as a Class A medical device by the Singapore Health Sciences Authority (HSA).
We also collaborate with international partners to introduce advanced automation, mass spectrometry-based metabolomics, and high-throughput omics workflows into Southeast Asia’s healthcare and research ecosystems—strengthening our mission to accelerate life sciences innovation and improve precision healthcare across the region.
